Prima facie the therapeutic implications may include the following: a decrease in the proliferation of EESC, invasion, vascularization, pain sensation, inflammation, gestational diabetes mellitus, and fetal growth restriction
Patients diagnosed with multiple sclerosis, autoimmune encephalitis, or cerebellar ataxia who report worsening symptoms during allergy seasons, chemical exposures, or high-stress periods may have a mast cell component exacerbating their condition
Consideration for Treatments Individuals suffering from schizophrenia display an increase in the activity of the dopaminergic system in the mesolimbic pathway
da Rosa CVD, Azevedo SC, Bazotte RB, Peralta RM, Buttow NC, Pedrosa MMD, et al
Water, Glycerin, Stearic Acid, Centella Asiatica Extract (8.4%), Lauric Acid, Potassium Hydroxide, Myristic Acid, 1,2-Hexanediol, Glycol Distearate, Coco-glucoside, Potassium Cocoyl Glycinate, Sorbitan Olivate, Glutathione (1,000ppm), Beeswax, Niacinamide (1,000ppm), Glyceryl Stearate, PEG-100 Stearate, Polysorbate 60, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Butylene Glycol, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Dipropylene Glycol, Hydroxypropyl Methylcellulose, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Sodium Hyaluronate, Disodium EDTA, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Cholesterol, Xanthan Gum
